0

    524689

    PARENTLD

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    PARENTERAL DRUGS (INDIA) LTD. Share Price Today

    PARENTERAL DRUGS (INDIA) LTD. is currently trading at ₹3.39, up by ₹0.0 from the previous close. The stock touched an intraday high of ₹3.39 and a low of ₹3.08 during the latest trading session. Over the past one year, PARENTERAL DRUGS (INDIA) LTD. has delivered a loss of 19.47%, while the stock has gained 9.7% in the last one month.

    Investment Returns

    Over 1 Month 9.70% Over 3 Months -15.67% Over 6 Months -25.65% Over 1 Year -19.47%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    PARENTERAL DRUGS (INDIA) LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 0.0
    • P/E Ratio (TTM) 0.0
    • Beta 0.0
    • Book Value / share 0.0
    • Return on equity 0.0%
    • EPS (TTM) 0.0
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.0
    info icon alternate text

    PARENTERAL DRUGS (INDIA) LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2022 (Values in Cr)
    Revenue 1.77
    Operating Expense 34.81
    Net Profit 23.81
    Net Profit Margin (%) 1345.19
    Earnings Per Share (EPS) 7.99
    EBITDA 46.36
    Effective Tax Rate (%) -23.94
    Particulars DEC 2021 (Values in Cr)
    Revenue 1.44
    Operating Expense 45.68
    Net Profit -34.52
    Net Profit Margin (%) -2397.22
    Earnings Per Share (EPS) -11.58
    EBITDA -3.21
    Effective Tax Rate (%) 21.93
    Particulars SEP 2021 (Values in Cr)
    Revenue 2.35
    Operating Expense 45.42
    Net Profit -33.61
    Net Profit Margin (%) -1430.21
    Earnings Per Share (EPS) -11.28
    EBITDA -3.24
    Effective Tax Rate (%) 21.92
    Particulars JUN 2021 (Values in Cr)
    Revenue 2.93
    Operating Expense 44.00
    Net Profit -32.04
    Net Profit Margin (%) -1093.51
    Earnings Per Share (EPS) -10.74
    EBITDA -2.61
    Effective Tax Rate (%) 21.97
    Particulars MAR 2021 (Values in Cr)
    Revenue 2.57
    Operating Expense 35.96
    Net Profit -24.84
    Net Profit Margin (%) -966.53
    Earnings Per Share (EPS) -8.33
    EBITDA 3.42
    Effective Tax Rate (%) 25.50
    Particulars MAR 2022 (Values in Cr)
    Revenue 8.50
    Operating Expense 169.91
    Net Profit -76.36
    Net Profit Margin (%) -898.35
    Earnings Per Share (EPS) -25.61
    EBITDA 37.27
    Effective Tax Rate (%) 30.01
    Particulars MAR 2021 (Values in Cr)
    Revenue 12.17
    Operating Expense 166.71
    Net Profit -121.71
    Net Profit Margin (%) -1000.08
    Earnings Per Share (EPS) -40.82
    EBITDA -11.70
    Effective Tax Rate (%) 21.20
    Particulars MAR 2020 (Values in Cr)
    Revenue 31.87
    Operating Expense 173.85
    Net Profit -114.07
    Net Profit Margin (%) -357.92
    Earnings Per Share (EPS) -38.26
    EBITDA -14.41
    Effective Tax Rate (%) 19.51
    Particulars MAR 2019 (Values in Cr)
    Revenue 32.03
    Operating Expense 214.85
    Net Profit -147.90
    Net Profit Margin (%) -461.75
    Earnings Per Share (EPS) -49.61
    EBITDA -16.23
    Effective Tax Rate (%) 18.46
    Particulars MAR 2018 (Values in Cr)
    Revenue 32.97
    Operating Expense 153.71
    Net Profit -96.09
    Net Profit Margin (%) -291.44
    Earnings Per Share (EPS) -32.24
    EBITDA -14.49
    Effective Tax Rate (%) 19.52
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share -264.78
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -96.22
    Particulars MAR 2020 (Values in Cr)
    Book Value / Share -224.01
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -45.28
    Particulars MAR 2019 (Values in Cr)
    Book Value / Share -185.65
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -50.67
    Particulars MAR 2018 (Values in Cr)
    Book Value / Share -148.33
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.19
    Particulars MAR 2017 (Values in Cr)
    Book Value / Share -108.42
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -7.00
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share -264.89
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -96.14
    Particulars MAR 2020 (Values in Cr)
    Book Value / Share -224.12
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -45.28
    Particulars MAR 2019 (Values in Cr)
    Book Value / Share -185.75
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -48.84
    Particulars MAR 2018 (Values in Cr)
    Book Value / Share -136.07
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -43.98
    Particulars MAR 2017 (Values in Cr)
    Book Value / Share -103.83
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -61.01
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 568.20
    Total Liabilities 568.20
    Total Equity -682.75
    Share Outstanding 2
    Price to Book Ratio -0.01
    Return on Assets (%) -21.42
    Return on Capital (%) 21.15
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 0.10
    Total Assets 551.85
    Total Liabilities 551.85
    Total Equity -561.18
    Share Outstanding 2
    Price to Book Ratio -0.01
    Return on Assets (%) -20.67
    Return on Capital (%) 25.13
    Particulars MAR 2019 (Values in Cr)
    Cash & Short Term Investments 0.44
    Total Assets 540.56
    Total Liabilities 540.56
    Total Equity -446.79
    Share Outstanding 2
    Price to Book Ratio -0.05
    Return on Assets (%) -27.36
    Return on Capital (%) 43.87
    Particulars MAR 2018 (Values in Cr)
    Cash & Short Term Investments 3.54
    Total Assets 890.42
    Total Liabilities 890.42
    Total Equity -136.15
    Share Outstanding 2
    Price to Book Ratio -0.12
    Return on Assets (%) -12.55
    Return on Capital (%) -24.79
    Particulars MAR 2017 (Values in Cr)
    Cash & Short Term Investments 3.22
    Total Assets 913.74
    Total Liabilities 913.74
    Total Equity -17.16
    Share Outstanding 2
    Price to Book Ratio -0.26
    Return on Assets (%) -12.89
    Return on Capital (%) -18.44
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 566.79
    Total Liabilities 566.79
    Total Equity -683.20
    Share Outstanding 2
    Price to Book Ratio -0.01
    Return on Assets (%) -21.47
    Return on Capital (%) 21.1
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 0.10
    Total Assets 550.43
    Total Liabilities 550.43
    Total Equity -561.63
    Share Outstanding 2
    Price to Book Ratio -0.01
    Return on Assets (%) -20.72
    Return on Capital (%) 25.05
    Particulars MAR 2019 (Values in Cr)
    Cash & Short Term Investments 0.44
    Total Assets 539.15
    Total Liabilities 539.15
    Total Equity -447.24
    Share Outstanding 2
    Price to Book Ratio -0.05
    Return on Assets (%) -27.43
    Return on Capital (%) 43.69
    Particulars MAR 2018 (Values in Cr)
    Cash & Short Term Investments 0.77
    Total Assets 764.32
    Total Liabilities 764.32
    Total Equity -107.77
    Share Outstanding 2
    Price to Book Ratio -0.12
    Return on Assets (%) -12.57
    Return on Capital (%) -26.64
    Particulars MAR 2017 (Values in Cr)
    Cash & Short Term Investments 0.96
    Total Assets 759.83
    Total Liabilities 759.83
    Total Equity -11.66
    Share Outstanding 2
    Price to Book Ratio -0.26
    Return on Assets (%) -15.01
    Return on Capital (%) -22.01
    Particulars MAR 2021 (Values in Cr)
    Net Income -154.47
    Cash from Operations 125.32
    Cash from Investing 0.06
    Cash from Financing -125.43
    Net change in Cash -0.05
    Free Cash Flow 125.32
    Particulars MAR 2020 (Values in Cr)
    Net Income -141.73
    Cash from Operations 112.36
    Cash from Investing 0.07
    Cash from Financing -112.42
    Net change in Cash 0.01
    Free Cash Flow 112.36
    Particulars MAR 2019 (Values in Cr)
    Net Income -181.39
    Cash from Operations 456.05
    Cash from Investing 96.57
    Cash from Financing -573.59
    Net change in Cash 0.01
    Free Cash Flow 456.05
    Particulars MAR 2018 (Values in Cr)
    Net Income -141.24
    Cash from Operations 166.95
    Cash from Investing -0.61
    Cash from Financing -166.61
    Net change in Cash -0.28
    Free Cash Flow 168.34
    Particulars MAR 2017 (Values in Cr)
    Net Income -127.38
    Cash from Operations 134.31
    Cash from Investing -0.53
    Cash from Financing -134.35
    Net change in Cash -0.48
    Free Cash Flow 134.74
    Particulars MAR 2021 (Values in Cr)
    Net Income -154.47
    Cash from Operations 125.32
    Cash from Investing 0.06
    Cash from Financing -125.43
    Net change in Cash -0.05
    Free Cash Flow 125.32
    Particulars MAR 2020 (Values in Cr)
    Net Income -141.73
    Cash from Operations 112.36
    Cash from Investing 0.07
    Cash from Financing -112.43
    Net change in Cash 0.01
    Free Cash Flow 112.36
    Particulars MAR 2019 (Values in Cr)
    Net Income -181.39
    Cash from Operations 455.78
    Cash from Investing 0.09
    Cash from Financing -455.79
    Net change in Cash 0.08
    Free Cash Flow 455.78
    Particulars MAR 2018 (Values in Cr)
    Net Income -119.40
    Cash from Operations 148.37
    Cash from Investing -0.75
    Cash from Financing -147.90
    Net change in Cash -0.27
    Free Cash Flow 149.73
    Particulars MAR 2017 (Values in Cr)
    Net Income -125.16
    Cash from Operations 120.98
    Cash from Investing -0.23
    Cash from Financing -120.63
    Net change in Cash 0.12
    Free Cash Flow 120.98
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.27 13.33 1.56 247.30 23.12 38.85
    BLISS GVS PHARMA LTD 488.65 39.28 4.34 5182.44 118.35 552.90
    CIPLA LTD 1471.25 31.22 3.45 118854.24 1165.55 1672.20
    FERMENTA BIOTECH LTD. 395.00 17.42 2.85 1162.52 256.40 401.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.27 22.57 4.15 247.30 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 531.30 23.81 4.14 1536.02 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8222.25 107.38 23.55 20555.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 488.65 52.83 4.48 5182.44 118.35 552.90

    PARENTERAL DRUGS (INDIA) LTD. shareholding pattern

    Holding
    26.7%
    73.28%
    94.5%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    PARENTERAL DRUGS (INDIA) LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    3.39 4.62 redarrow
    red-green-graph indicator
    0 Bearish
    0 Bullish
    • 5 Days 0.00
    • 26 Days 0.00
    • 10 Days 0.00
    • 50 Days 0.00
    • 12 Days 0.00
    • 100 Days 0.00
    • 20 Days 0.00
    • 200 Days 0.00
    0.0 PIVOT
    First Support 0.0 First Resistance 0.0 Second Support 0.0 Second Resistance 0.0 Third Support 0.0 Third Resistance 0.0
    RSI 0.0 ADX 0.0 MACD 0.0 Williams % R 0.0 Commodity Channel Index (CCI) 0.0
    Date [-] Week 0.0 Same Day 0.0 Month 0.0
    1 Year 0.0 3 Year 0.0
    Over 1 Month
    9.70% down
    Over 1 Year
    -19.47% down
    Over 3 Months
    -15.67% down
    Over 3 Years
    8.96% down
    Over 6 Months
    -25.65% down
    Over 5 Years
    -19.83% down

    PARENTERAL DRUGS (INDIA) LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    13 Sep 2010 2.0 Final 15 Sep 2010 Equity shares
    23 Dec 2009 1.5 Final 25 Dec 2009 Equity shares
    24 Sep 2008 1.5 Final 26 Sep 2008 Equity shares
    21 Sep 2007 1.5 Final 25 Sep 2007 Equity shares
    Ex-Date Ex-Bonus Ratio
    15 Sep 2010 13 Sep 2010 1:3
    05 Nov 2007 02 Nov 2007 1:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Parenteral Drugs (India) Ltd?

    Answer Field

    Parenteral Drugs (India) Ltd share price is for NSE ₹ 2.90 & for BSE ₹ 3.39 as on Aug 21 2023 12:00 AM.

    What is the Market Cap of Parenteral Drugs (India) Ltd Share?

    Answer Field

    The market cap of Parenteral Drugs (India) Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 21 2023 12:00 AM.

    What is the 52 Week High and Low of Parenteral Drugs (India) Ltd?

    Answer Field

    The 52 Week High and Low of Parenteral Drugs (India) Ltd for NSE is ₹ 2.90 and ₹ 0.00 and for BSE is ₹ 3.39 and ₹ 0.00.

    What is 1 year return for Parenteral Drugs (India) Ltd?

    Answer Field

    The 1 year returns on the stock has been -19.47%.

    What is the P/E Ratio of Parenteral Drugs (India) Ltd Share?

    Answer Field

    As on Aug 21 2023 12:00 AM the price-to-earnings (PE) ratio for Parenteral Drugs (India) Ltd share is 0.0.

    What is the PB ratio of Parenteral Drugs (India) Ltd Share?

    Answer Field

    As on Aug 21 2023 12:00 AM, the price-to-book (PB) ratio for Parenteral Drugs (India) Ltd share is 0.0.

    How to Buy Parenteral Drugs (India) Ltd Share?

    Answer Field

    You can trade in Parenteral Drugs (India) Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Parenteral Drugs (India) Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Parenteral Drugs (India) Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Parenteral Drugs (India) Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |